STOCK TITAN

Notifications

Limited Time Offer! Get Platinum at the Gold price until January 31, 2026!

Sign up now and unlock all premium features at an incredible discount.

Read more on the Pricing page

Myriad Genetics to Present at 43rd Annual J.P. Morgan Healthcare Conference

Rhea-AI Impact
(Low)
Rhea-AI Sentiment
(Neutral)
Tags
conferences

Myriad Genetics (NASDAQ: MYGN) has announced its participation in the 43rd Annual J.P. Morgan Healthcare Conference in San Francisco. The company's management team will deliver a presentation on Wednesday, January 15, at 3:45 PM PT (6:45 PM ET).

Interested parties can access the presentation through a live webcast available in the investor relations section of Myriad's website at investor.myriad.com. For those unable to attend the live session, an archived version of the presentation will be made available on the same day.

Loading...
Loading translation...

Positive

  • None.

Negative

  • None.

SALT LAKE CITY, Jan. 08, 2025 (GLOBE NEWSWIRE) -- Myriad Genetics, Inc. (NASDAQ: MYGN), a leader in genetic testing and precision medicine, today announced members of its management team will present at the 43rd Annual J.P. Morgan Healthcare Conference in San Francisco on Wednesday, Jan. 15, at 3:45pm PT (6:45pm ET).

The presentation will be available through a live webcast in the investor relations section of Myriad’s website at investor.myriad.com. An archived edition of the presentation will be available later that day.

About Myriad Genetics
Myriad Genetics is a leading genetic testing and precision medicine company dedicated to advancing health and well-being for all. Myriad develops and offers genetic tests that help assess the risk of developing disease or disease progression and guide treatment decisions across medical specialties where genetic insights can significantly improve patient care and lower healthcare costs. For more information, visit www.myriad.com.

Investor Contact
Matt Scalo
(801) 584-3532
IR@myriad.com

Media Contact
Glenn Farrell
(385) 318-3718
PR@myriad.com


FAQ

When is Myriad Genetics (MYGN) presenting at the 2025 J.P. Morgan Healthcare Conference?

Myriad Genetics will present on Wednesday, January 15, 2025, at 3:45 PM PT (6:45 PM ET).

How can investors watch Myriad Genetics' (MYGN) J.P. Morgan Healthcare Conference presentation?

Investors can watch the presentation through a live webcast available in the investor relations section of Myriad's website at investor.myriad.com.

Will Myriad Genetics' (MYGN) J.P. Morgan Healthcare Conference presentation be available after the event?

Yes, an archived version of the presentation will be available on the same day through Myriad's investor relations website.

Which Myriad Genetics (MYGN) executives will present at the 2025 J.P. Morgan Healthcare Conference?

The press release indicates that members of Myriad Genetics' management team will present, but specific executives are not named.
Myriad Genetics

NASDAQ:MYGN

MYGN Rankings

MYGN Latest News

MYGN Latest SEC Filings

MYGN Stock Data

737.32M
90.13M
2.9%
98.4%
9.66%
Diagnostics & Research
In Vitro & in Vivo Diagnostic Substances
Link
United States
SALT LAKE CITY